Effects of neonatal dopamine depletion on sensory inhibition in the rat

Pharmacology Biochemistry and Behavior

Volumn 53, Issue 4, 1996, Pages 817-823

  Stevens, Karen E ^b   Luthman, Johan ^b   Lindqvist, Eva ^b   Johnson, Robert G ^b   Rose, Gregory M ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

6 Hydroxydopamine; Amphetamine; Apomorphine; Evoked potentials; Sensory gating

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; APOMORPHINE; DESIPRAMINE; DEXAMPHETAMINE; DOPAMINE; DOPAMINE RECEPTOR; HOMOVANILLIC ACID; NORADRENALIN; OXIDOPAMINE; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEPLETION; DOPAMINERGIC TRANSMISSION; ELECTROPHYSIOLOGY; EVOKED AUDITORY RESPONSE; INFORMATION PROCESSING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEWBORN; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SENSORY SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ANIMALIA;

EID: 0029975035     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02083-7     Document Type: Article

References (47)

1. Adler, L. E.; Gerhardt, G. A.; Franks, R.; Baker, N.; Nagamoto, H.; Drebing, C.; Freedman, R. Sensory physiology and catecholamines in schizophrenia and mania. Psychiatry Res. 31:297-309; 1990.
2. Adler, L. E.; Pachtman, E.; Franks, R. D.; Pecevich, M.; Waldo, M. C.; Freedman, R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol. Psychiatry 17:639-654; 1982.
3. Adler, L. E.; Pang, K.; Gerhardt, G.; Rose, G. M. Modulation of the gating of auditory evoked potentials by norepinephrine: Pharmacological evidence obtained using a selective neurotoxin. Biol. Psychiatry 24:179-180; 1988.
4. Adler, L. E.; Rose, G.; Freedman, R. Neurophysiological studies of sensory gating in rats: Effects of amphetamine, phencyclidine and haloperidol. Biol. Psychiatry 21:787-798; 1986.
5. Archer, T.; Danysz, W.; Fredriksson, A.; Jonsson, G.; Luthman, J.; Sundström, E.; Teiling, A. Neonatal 6-hydroxydopamine-induced dopamine depletions: Motor activity and performance in maze learning. Pharmacol. Biochem. Behav. 31:357-364; 1988.
6. Baker, N.; Adler, L. E.; Franks, R. D.; Waldo, M.; Berry, S.; Nagamoto, H.; Muckle, A.; Freedman, R. Neurophysiological assessment of gating of sensory input: Comparison between schizophrenia and other diagnoses. Biol. Psychiatry 22:603-617; 1987.
7. Bickford-Wimer, P. C.; Nagamoto, H.; Johnson, R.; Adler, L. E.; Rose, G. M.; Freedman, R. Auditory gating in hippocampal neurons: A model system in the rat. Biol. Psychiatry 27:189-192; 1990.
8. Bloom, F. E.; Algeri, S.; Groppetti, A.; Revuelta, S.; Costa, E. Lesions of central norepinephrine terminals with 6-OH-dopamine: Biochemistry and fine structure. Science 166:1284-1286; 1969.
9. Breese, G. R.; Baumeister, A.; McCown, T. J.; Emerick, S. G.; Frye, G. D.; Crotty, K.; Mueller, R. A. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: Relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. J. Pharmacol. Exp. Ther. 231:343-354; 1985.
10. 1 dopamine receptors in neonatally lesioned rats. J. Pharmacol. Exp. Ther. 234:447-455; 1985.
11. Breese, G. R.; Traylor, T. D. Depletion of noradrenaline and dopamine with 6-hydroxydopamine. Br. J. Pharmacol., 42:88-99; 1971.
12. Bruno, J. P.; Snyder, A. M.; Stricker, E. M. Effect of dopamine-depleting brain lesions on suckling and weaning in rats. Behav. Neurosci. 98:156-161; 1984.
13. 1 supersensitivity in the rat striatum after unilateral 6-hydroxydopamine lesions. Eur. J. Pharmacol. 126: 347-348; 1986.
14. Caldwell, J.; Sever, P. S. The biochemical pharmacology of abused drugs. I. Amphetamines, cocaine, and LSD. Clin. Pharmacol. Ther. 16:625-638; 1974.
15. Castaneda, E.; Whishaw, I. Q.; Lermer, L.; Robinson, T. E. Dopamine depletion in neonatal rats: Effects on behavior and striatal dopamine release assessed by intracerebral microdialysis during adulthood. Brain Res. 508:30-39; 1990.
16. Cowburn, R.; Young, D.; Luthman, J. Enhanced adenylate cyclase activity in neonatally dopamine lesioned rats is related to increased Gs-protein coupling. Eur. J. Pharmacol. 207:271-274; 1991.
17. Davis, M. Apomorphine, d-amphetamine, strychnine and yohimbine do not alter prepulse inhibition of the acoustic startle reflex. Psychopharmacology (Berlin) 95:151-156; 1988.
18. Davis, M.; Mansbach, R. S.; Swerdlow, N. R.; Campeau, S.; Braff, D. L.; Geyer, M. A. Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulses in rats. Psychopharmacology (Berlin) 120:1-4; 1990.
19. 1 receptors in adult rat neostriatum after neonatal 6-hydroxydopamine denervation. Brain Res. 536:287-296; 1990.
20. Duncan, G. E.; Criswell, H. E.; McCown, T. J.; Paul, I. A.; Mueller, R. A.; Breese, G. R. Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine. J. Pharmacol. Exp. Ther. 243:1027-1034; 1987.
21. Eccles, J. C. The inhibitory pathways of the central nervous system. Liverpool: Liverpool University Press; 1969.
22. Erinoff, L.; MacPhail, R. C.; Heller, A.; Seiden, L. S. Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat. Brain Res. 164:195-205; 1979.
23. Freedman, R.; Adler, L. E.; Gerhardt, G. A.; Waldo, M.; Baker, N.; Rose, G. M.; Drebing, C.; Nagamoto, H.; Bickford-Wimer, P.; Franks, R. Neurobiological studies of sensory gating in schizophrenia. Schizophr. Bull. 13:669-678; 1987.
24. Herrera-Marshitz, M.; Luthman, J.; Ferré, S. Unilateral neonatal intracerebroventricular 6-hydroxydopamine administration in rats: II. Effects on extracellular monoamine, acetylcholine and adenosine levels monitored with in vivo microdialysis. Psychopharmacology (Berlin) 116:451-456; 1994.
25. 2 receptors in the control of sensorimotor behavior. Soc. Neurosci. Absr. 15:560; 1989.
26. Luthman, J.; Bolioli, B.; Tsutsumi, T.; Verhofstad, A.; Jonsson, G. Sprouting of striatal serotonin nerve terminals following selective lesions of nigro-striatal dopamine neurons in the neonatal rat. Brain Res. Bull. 19:269-274; 1987.
27. Luthman, J.; Cowburn, R.; De Simoni, M. G.; Renyi, I. Plasticity responses after neonatal dopamine lesions induced with 6-hydroxydopamine. In: Fuxe, K.; Agnati, L. F.; Bjelke, B.; Ottosson D., eds. Trophic regulation of the basal ganglia. Wenner-Gren International Series. Vol. 62. Oxford: Pergamon; 1994:479-501.
28. Luthman, J.; Fredriksson, A.; Sundström, E.; Jonsson, G.; Archer, T. Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: Motor behavior and monoamine alterations at adult stage. Behav. Brain Res. 33:267-277; 1989.
29. Luthman, J.; Lindqvist, E.; Ögren, S. O. Hyperactivity in neonatally dopamine lesioned rats requires residual activity in mesolimbic dopamine neurons. Pharmacol. Biochem. Behav. 51:159-163; 1995.
30. Luthman, J.; Lindqvist, E.; Young, D.; Cowburn, R. Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamineand adenosine 3′,5′-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity. Exp. Brain Res. 83:85-95; 1990.
31. Marshall, J. F.; Richardson, J. S.; Teitelbaum, P. Nigrostriatal bundle damage and the lateral hypothalamic syndrome. J. Comp. Physiol. Psychol. 87:808-830; 1974.
32. 2 receptors in adult rat neostriatum after neonatal dopamine denervation: Quantitative data from ligand binding, in situ hybridization and iontophoresis. Neuroscience 57:635-648; 1993.
33. Schwarzkopf, S. B.; Mitra, T.; Bruno, J. P. Sensory gating in rats depleted of dopamine as neonates: Potential relevance to findings in schizophrenic patients. Biol. Psychiatry 31:759-773; 1992.
34. Shaywitz, B. A.; Yager, R. D.; Klopper, J. H. Selective brain dopamine depletion in developing rats: An experimental model of minimal brain dysfunction. Science 191:305-307; 1976.
35. Sivam, S. P.; Breese, G. E.; Krause, J. E.; Napier, T. C.; Mueller, R. A.; Hong, J. Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression. J. Neurochem. 49:1623-1633; 1987.
36. Stevens, K. E.; Fuller, L. L.; Rose, G. M. Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating. Brain Res. 555:91-98; 1991.
37. Stevens, K. E.; Harris, K. R.; Lehman, J. C.; Stryker, S. L.; Rose, G. M. Dopamine autoreceptor antagonist AJ76 disrupts auditory sensory gating in rats. Soc. Neurosci. Absr. 18:1514; 1992.
38. 1A antagonist, normalizes amphetamine-induced loss of auditory gating in freely moving rats. Schizophr. Res. 15:186; 1995.
39. Stevens, K. E.; Meltzer, J.; Rose, G. M. Disruption of sensory gating by the alpha-2 selective noradrenergic antagonist yohimbine. Biol. Psychiatry 33:130-132; 1993.
40. 2 adrenergic blockade with yohimbine disrupts auditory sensory gating in rats. Soc. Neurosci. Absr. 17:1454; 1991.
41. Ungerstedt, U. 6-hydroxydopamine induced degeneration of central monoamine neurons. Eur. J. Pharmacol. 5:107-110; 1968.
42. Ungerstedt, U. Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand. Suppl. 367:95-122; 1971.
43. Venables, P. Input dysfunction in schizophrenia. In: Maher, B. A., ed. Progress in experimental personality research. Orlando: Academic Press; 1964:1-47.
44. Venables, P. H. Hippocampal function and schizophrenia. Experimental psychological evidence. Ann. NY Acad. Sci. 658:111-127; 1992.
45. Weihmuller, F. B.; Bruno, J. P. Drinking behavior and motor function in rat pups depleted of brain dopamine during development. Dev. Psychobiol. 22:101-113; 1989.
46. Weihmuller, F. B.; Bruno, J. P. Age-dependent plasticity in the dopaminergic control of sensorimotor development. Behav. Brain Res. 35:95-109; 1989.
47. Zigmond, M. J.; Stricker, E. M. Deficits in feeding behavior after intraventricular injection of 6-hydroxydopamine in rats. Science 177:1211-1214; 1972.